鉄欠乏性貧血治療薬の世界市場レポート 2025年

鉄欠乏性貧血治療薬の市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR7.8%で65億1,000万米ドルに成長します。予測期間中の成長は、販促活動の活発化、啓発キャンペーン、専門医療パイプラインの拡充、栄養欠乏症の増加と食生活の変化、鉄ベースの治療選択肢の拡大、妊産婦の鉄欠乏症の発生率の増加など、いくつかの要因に起因すると考えられます。この期間に注目すべき主な動向には、鉄をターゲットにしたナノテクノロジー、ウェアラブル健康モニター、スマート鉄サプリメント、血中鉄バイオセンサー、ターゲット鉄デリバリー用に設計されたナノロボットの開発が含まれます。

慢性疾患の有病率の増加は、今後数年間の鉄欠乏性貧血治療薬市場の成長を大きく促進すると予想されます。慢性疾患は、通常1年以上続く長期的な病状です。これらの疾患の増加は、食生活の乱れ、運動不足、喫煙などの不健康なライフスタイル要因に起因しており、肥満、糖尿病、心臓病などの症状の一因となっています。これらの慢性疾患は、鉄を適切に吸収する体内の能力を妨げ、鉄欠乏のリスクを高め、鉄レベルを回復させるためのサプリメントや治療薬の必要性を高めます。例えば、2024年6月、英国の国民保健サービス（NHS）は、2023年にGPに登録された361万5,330人が非糖尿病性高血糖（糖尿病予備軍）と診断され、2022年に記録された306万5825例から18％増加したと報告しました。慢性疾患の症例数の増加に伴い、鉄欠乏性貧血治療薬の需要も増加の一途をたどっています。

鉄欠乏性貧血治療薬市場の主要企業は、有効性とアクセシビリティを向上させるため、注射製剤などの治療オプションの進歩にますます注力しています。注射製剤とは、新たに開発された、あるいは改良された薬剤を注射によって投与するもので、従来の経口サプリメントに比べ、より効果的で利便性の高いアプローチを提供します。例えば、2023年5月、インドの製薬会社であるエムキュア・ファーマシューティカルズ社は、鉄欠乏症や鉄欠乏性貧血（IDA）の治療用に設計されたカルボキシマルトース鉄（FCM）製剤であるオロファーFCM750を発売しました。この製剤の利点は、経口サプリメントに比べて投与回数が少ないため、患者のコンプライアンスが向上することです。オロファーFCM750は750mg/15mlの注射剤で、経口鉄剤に反応しない患者、特にヘモグロビン値が10g/dL未満で体重が35～70kgの妊婦の鉄欠乏性貧血の治療薬としてインドのDCGIから承認されています。生理食塩水で希釈すると15分間の点滴が可能で、Anemia Mukt Bharatガイドラインに沿った重症例に対する第一選択治療薬です。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場のマクロ経済シナリオ：金利・インフレ・地政学・貿易戦争・関税・コロナ禍と回復が市場に及ぼす影響を含む

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の鉄欠乏性貧血治療薬市場：PESTEL分析（政治・社会・技術・環境・法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の鉄欠乏性貧血治療薬市場：成長率分析
• 世界の鉄欠乏性貧血治療薬の市場規模・成長率：実績値、2019～2024年
• 世界の鉄欠乏性貧血治療薬の市場規模・成長率：予測値、2024～2029年、2034年
• 世界の鉄欠乏性貧血治療薬市場：総有効市場（TAM）

第6章 市場セグメンテーション

• 世界の鉄欠乏性貧血治療薬市場：製品種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 硫酸第一鉄
• グルコン酸第一鉄
• フマル酸第一鉄
• 水酸化鉄
• 世界の鉄欠乏性貧血治療薬市場：治療薬の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 非経口鉄療法
• 経口鉄療法
• 赤血球輸血
• その他の治療法
• 世界の鉄欠乏性貧血治療薬市場：治療領域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 炎症性腸疾患
• 腎臓疾患
• 産婦人科
• うっ血性心不全
• 腫瘍学
• 世界の鉄欠乏性貧血治療薬市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院薬局
• ドラッグストアと薬局
• オンライン薬局
• 世界の鉄欠乏性貧血治療薬市場：エンドユーザー別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 病院
• 専門クリニック
• 在宅医療
• その他のエンドユーザー
• 世界の鉄欠乏性貧血治療薬市場：硫酸第一鉄の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 経口硫酸第一鉄錠
• 経口液状硫酸第一鉄
• 静脈内硫酸第一鉄
• 徐放性製剤
• 世界の鉄欠乏性貧血治療薬市場：グルコン酸第一鉄の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 経口錠
• チュアブル錠
• 液体ソリューション
• 小児用製剤
• 世界の鉄欠乏性貧血治療薬市場：フマル酸第一鉄の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 経口錠剤またはカプセル
• 妊娠前サプリメント
• 鉄分配合マルチビタミン
• 小児用ドロップまたはシロップ
• 世界の鉄欠乏性貧血治療薬市場：水酸化鉄の種類別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 静脈内鉄療法
• 水酸化鉄ポリマルトース複合体
• 透析特異的鉄療法
• 病院ベースの注射剤

第7章 地域別・国別の分析

• 世界の鉄欠乏性貧血治療薬市場：地域別、実績値・予測値、2019～2024年、2024～2029年、2034年
• 世界の鉄欠乏性貧血治療薬市場：国別、実績値・予測値、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 鉄欠乏性貧血治療薬市場：競合情勢
• 鉄欠乏性貧血治療薬市場：企業プロファイル
  • Sanofi SA（概要、製品・サービス、戦略、財務分析）
  • Fresenius SE & Co. KGaA（概要、製品・サービス、戦略、財務分析）
  • GlaxoSmithKline plc（概要、製品・サービス、戦略、財務分析）
  • Sun Pharmaceutical Industries Ltd（概要、製品・サービス、戦略、財務分析）
  • CSL Vifor AG（概要、製品・サービス、戦略、財務分析）

第31章 その他の大手企業と革新的企業

• Zydus Lifesciences Limited
• Alkem Laboratories Ltd.
• Luitpold Pharmaceuticals Inc.
• Covis Pharma GmbH
• Pharmacosmos Therapeutics Inc.
• AFT Pharmaceuticals Ltd.
• Rockwell Medical Inc.
• Akebia Therapeutics Inc.
• Otsuka Pharmaceutical Co Ltd
• AdvaCare Pharma USA LLC
• Apotex Inc.
• Ironic Biotech AB
• KYE Pharmaceuticals Inc.
• Emcure Pharmaceuticals Limited
• Shield Therapeutics plc

第32章 世界市場：競合ベンチマーキング・ダッシュボード

第33章 主要な企業合併・買収 (M&A)

第34章 最近の市場動向

第35章 市場の潜在力の高い国・部門と戦略

• 鉄欠乏性貧血治療薬市場：最新機会を提供する国（2029年）
• 鉄欠乏性貧血治療薬市場：最新機会を提供する部門（2029年）
• 鉄欠乏性貧血治療薬市場：成長戦略（2029年）
  • 市場動向に基づく戦略
  • 競争戦略

第36章 付録

Iron deficiency anemia therapy involves a comprehensive approach focused on restoring iron levels in the body to support normal red blood cell production. The primary objective is to treat the root cause of the iron deficiency, which may include changes in diet, iron supplementation, or medical treatment when necessary.

Key product types used in this therapy include ferrous sulfate, ferrous gluconate, ferrous fumarate, and ferric hydroxide. Ferrous sulfate is one of the most widely used supplements for treating iron deficiency anemia. These products are utilized across different therapy types such as oral iron therapy, parenteral iron therapy, red blood cell transfusions, and more. The therapy is applied in multiple medical areas including inflammatory bowel diseases, renal disorders, obstetrics and gynecology, congestive heart failure, and oncology. Distribution takes place through hospital pharmacies, retail pharmacies, drug stores, and online platforms. The end users of these therapies include hospitals, specialty clinics, home care settings, and other healthcare providers.

The iron deficiency anemia therapy market research report is one of a series of new reports from The Business Research Company that provides iron deficiency anemia therapy market statistics, including iron deficiency anemia therapy industry global market size, regional shares, competitors with a iron deficiency anemia therapy market share, iron deficiency anemia therapy market segments, market trends and opportunities, and any further data you may need to thrive in the iron deficiency anemia therapy industry. This iron deficiency anemia therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iron deficiency anemia therapy market size has grown strongly in recent years. It will grow from $4.46 billion in 2024 to $4.82 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth during the historic period can be attributed to several factors, including increased research and development, the introduction of novel drugs, advancements in iron supplementation, the rising prevalence of iron deficiency anemia, a stronger focus on social healthcare, and improvements in available treatment options.

The iron deficiency anemia therapy market size is expected to see strong growth in the next few years. It will grow to $6.51 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The projected growth in the forecast period can be attributed to several factors, including increased promotional activities, awareness campaigns, the expansion of specialized medicine pipelines, rising nutritional deficiencies and dietary changes, a broader range of iron-based therapy options, and the growing incidence of maternal iron deficiency. Key trends to watch during this period include the development of iron-targeting nanotechnology, wearable health monitors, smart iron supplements, blood iron biosensors, and nanorobots designed for targeted iron delivery.

The growing prevalence of chronic diseases is expected to significantly fuel the growth of the iron deficiency anemia therapy market in the coming years. Chronic diseases are long-term medical conditions that typically last for a year or more. The rise in these diseases can be attributed to unhealthy lifestyle factors, such as poor diet, lack of physical activity, and smoking, which contribute to conditions including obesity, diabetes, and heart disease. These chronic conditions can hinder the body's ability to absorb iron properly, increasing the risk of iron deficiency and thereby creating a greater need for supplementation and therapy to restore iron levels. For example, in June 2024, the National Health Service (NHS) of the United Kingdom reported that 3,615,330 individuals registered with a GP were diagnosed with non-diabetic hyperglycemia (pre-diabetes) in 2023, representing an 18% increase from the 3,065,825 cases recorded in 2022. As the number of chronic disease cases rises, the demand for iron deficiency anemia therapy continues to grow.

Leading companies in the iron deficiency anemia therapy market are increasingly focused on advancing treatment options, such as injectable formulations, to improve efficacy and accessibility. Injectable formulations are newly developed or modified drug versions administered via injection, offering a more effective and convenient approach compared to traditional oral supplements. For example, in May 2023, Emcure Pharmaceuticals Ltd., an India-based pharmaceutical company, launched Orofer FCM 750, a ferric carboxymaltose (FCM) formulation designed to treat iron deficiency and iron deficiency anemia (IDA). The benefits of this formulation include improved patient compliance due to less frequent administration compared to oral supplements. Orofer FCM 750 is a 750 mg/15 ml injectable that has been approved by India's DCGI for treating IDA in patients who are unresponsive to oral iron, particularly for pregnant women with hemoglobin levels below 10 g/dL and a weight range of 35-70 kg. It provides a 15-minute infusion when diluted in saline, aligning with Anemia Mukt Bharat guidelines as a first-line treatment for severe cases.

In August 2022, CSL Limited, an Australia-based biotechnology company specializing in iron deficiency injectables, acquired Vifor Pharma for an undisclosed amount. This acquisition strengthens CSL's commitment to patient care and enhances its capacity to offer innovative treatments. Vifor Pharma Ltd. is a Switzerland-based pharmaceutical company, focusing on providing therapies for iron deficiency and iron deficiency anemia.

Major players in the iron deficiency anemia therapy market are Sanofi SA, Fresenius SE & Co. KGaA, GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., CSL Vifor AG, Zydus Lifesciences Limited, Alkem Laboratories Ltd., Luitpold Pharmaceuticals Inc., Covis Pharma GmbH, Pharmacosmos Therapeutics Inc., AFT Pharmaceuticals Ltd., Rockwell Medical Inc., Akebia Therapeutics Inc., Otsuka Pharmaceutical Co. Ltd., AdvaCare Pharma USA LLC, Apotex Inc., Ironic Biotech AB, KYE Pharmaceuticals Inc., Emcure Pharmaceuticals Limited, and Shield Therapeutics plc.

North America was the largest region in the iron deficiency anemia therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in iron deficiency anemia therapy report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the iron deficiency anemia therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The iron deficiency anemia therapy market consists of revenues earned by entities by providing services such as iron supplementation, diagnostic services, nutritional counseling, home healthcare services, and patient education. The market value includes the value of related goods sold by the service provider or included within the service offering. The iron deficiency anemia therapy market also includes sales of oral iron supplements, intravenous (IV) iron preparations, erythropoiesis-stimulating agents, iron-fortified foods, and blood transfusion products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Iron Deficiency Anemia Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on iron deficiency anemia therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for iron deficiency anemia therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The iron deficiency anemia therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Ferrous Sulphate; Ferrous Gluconate; Ferrous Fumerate; Ferric Hydroxide
• 2) By Therapy Type: Parenteral Iron Therapy; Oral Iron Therapy; Red Blood Cell Transfusion; Other Therapy Types
• 3) By Therapy Areas: Inflammatory Bowel Diseases; Renal Diseases; Obstetrics and Gynecology; Congestive Heart Failure; Oncology
• 4) By Distribution channel: Hospital Pharmacy; Drug Stores And Retail Pharmacies; Online Pharmacies
• 5) By End User: Hospitals; Speciality Clinics; Home Care Setting; Other End Users
• Subsegments:
• 1) By Ferrous Sulphate: Oral Ferrous Sulphate Tablets; Oral Liquid Ferrous Sulphate; Intravenous Ferrous Sulphate; Extended Or Delayed Release Formulations
• 2) By Ferrous Gluconate: Oral Tablets; Chewable Tablets; Liquid Solutions; Pediatric Formulations
• 3) By Ferrous Fumarate: Oral Tablets Or Capsules; Prenatal Supplements; Multivitamin with Iron Formulations; Pediatric Drops Or Syrups
• 4) By Ferric Hydroxide: Intravenous Iron Therapy; Ferric Hydroxide Polymaltose Complex; Dialysis-Specific Iron Therapy; Hospital-Based Injectable Formulations
• Companies Mentioned: Sanofi SA; Fresenius SE & Co. KGaA; GlaxoSmithKline plc; Sun Pharmaceutical Industries Ltd; CSL Vifor AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Iron Deficiency Anemia Therapy Market Characteristics

3. Iron Deficiency Anemia Therapy Market Trends And Strategies

4. Iron Deficiency Anemia Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Iron Deficiency Anemia Therapy Growth Analysis And Strategic Analysis Framework

• 5.1. Global Iron Deficiency Anemia Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Iron Deficiency Anemia Therapy Market Growth Rate Analysis
• 5.4. Global Iron Deficiency Anemia Therapy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Iron Deficiency Anemia Therapy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Iron Deficiency Anemia Therapy Total Addressable Market (TAM)

6. Iron Deficiency Anemia Therapy Market Segmentation

• 6.1. Global Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ferrous Sulphate
• Ferrous Gluconate
• Ferrous Fumerate
• Ferric Hydroxide
• 6.2. Global Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Parenteral Iron Therapy
• Oral Iron Therapy
• Red Blood Cell Transfusion
• Other Therapy Types
• 6.3. Global Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inflammatory Bowel Diseases
• Renal Diseases
• Obstetrics and Gynecology
• Congestive Heart Failure
• Oncology
• 6.4. Global Iron Deficiency Anemia Therapy Market, Segmentation By Distribution channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacy
• Drug Stores And Retail Pharmacies
• Online Pharmacies
• 6.5. Global Iron Deficiency Anemia Therapy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Speciality Clinics
• Home Care Setting
• Other End Users
• 6.6. Global Iron Deficiency Anemia Therapy Market, Sub-Segmentation Of Ferrous Sulphate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Ferrous Sulphate Tablets
• Oral Liquid Ferrous Sulphate
• Intravenous Ferrous Sulphate
• Extended Or Delayed Release Formulations
• 6.7. Global Iron Deficiency Anemia Therapy Market, Sub-Segmentation Of Ferrous Gluconate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tablets
• Chewable Tablets
• Liquid Solutions
• Pediatric Formulations
• 6.8. Global Iron Deficiency Anemia Therapy Market, Sub-Segmentation Of Ferrous Fumarate, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral Tablets Or Capsules
• Prenatal Supplements
• Multivitamin With Iron Formulations
• Pediatric Drops Or Syrups
• 6.9. Global Iron Deficiency Anemia Therapy Market, Sub-Segmentation Of Ferric Hydroxide, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intravenous Iron Therapy
• Ferric Hydroxide Polymaltose Complex
• Dialysis-Specific Iron Therapy
• Hospital-Based Injectable Formulations

7. Iron Deficiency Anemia Therapy Market Regional And Country Analysis

• 7.1. Global Iron Deficiency Anemia Therapy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Iron Deficiency Anemia Therapy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Iron Deficiency Anemia Therapy Market

• 8.1. Asia-Pacific Iron Deficiency Anemia Therapy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Iron Deficiency Anemia Therapy Market

• 9.1. China Iron Deficiency Anemia Therapy Market Overview
• 9.2. China Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Iron Deficiency Anemia Therapy Market

• 10.1. India Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Iron Deficiency Anemia Therapy Market

• 11.1. Japan Iron Deficiency Anemia Therapy Market Overview
• 11.2. Japan Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Iron Deficiency Anemia Therapy Market

• 12.1. Australia Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Iron Deficiency Anemia Therapy Market

• 13.1. Indonesia Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Iron Deficiency Anemia Therapy Market

• 14.1. South Korea Iron Deficiency Anemia Therapy Market Overview
• 14.2. South Korea Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Iron Deficiency Anemia Therapy Market

• 15.1. Western Europe Iron Deficiency Anemia Therapy Market Overview
• 15.2. Western Europe Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Iron Deficiency Anemia Therapy Market

• 16.1. UK Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Iron Deficiency Anemia Therapy Market

• 17.1. Germany Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Iron Deficiency Anemia Therapy Market

• 18.1. France Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Iron Deficiency Anemia Therapy Market

• 19.1. Italy Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Iron Deficiency Anemia Therapy Market

• 20.1. Spain Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Iron Deficiency Anemia Therapy Market

• 21.1. Eastern Europe Iron Deficiency Anemia Therapy Market Overview
• 21.2. Eastern Europe Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Iron Deficiency Anemia Therapy Market

• 22.1. Russia Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Iron Deficiency Anemia Therapy Market

• 23.1. North America Iron Deficiency Anemia Therapy Market Overview
• 23.2. North America Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Iron Deficiency Anemia Therapy Market

• 24.1. USA Iron Deficiency Anemia Therapy Market Overview
• 24.2. USA Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Iron Deficiency Anemia Therapy Market

• 25.1. Canada Iron Deficiency Anemia Therapy Market Overview
• 25.2. Canada Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Iron Deficiency Anemia Therapy Market

• 26.1. South America Iron Deficiency Anemia Therapy Market Overview
• 26.2. South America Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Iron Deficiency Anemia Therapy Market

• 27.1. Brazil Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Iron Deficiency Anemia Therapy Market

• 28.1. Middle East Iron Deficiency Anemia Therapy Market Overview
• 28.2. Middle East Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Iron Deficiency Anemia Therapy Market

• 29.1. Africa Iron Deficiency Anemia Therapy Market Overview
• 29.2. Africa Iron Deficiency Anemia Therapy Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Iron Deficiency Anemia Therapy Market, Segmentation By Therapy Areas, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Iron Deficiency Anemia Therapy Market Competitive Landscape And Company Profiles

• 30.1. Iron Deficiency Anemia Therapy Market Competitive Landscape
• 30.2. Iron Deficiency Anemia Therapy Market Company Profiles
  • 30.2.1. Sanofi SA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Fresenius SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. GlaxoSmithKline plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Sun Pharmaceutical Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. CSL Vifor AG Overview, Products and Services, Strategy and Financial Analysis

31. Iron Deficiency Anemia Therapy Market Other Major And Innovative Companies

• 31.1. Zydus Lifesciences Limited
• 31.2. Alkem Laboratories Ltd.
• 31.3. Luitpold Pharmaceuticals Inc.
• 31.4. Covis Pharma GmbH
• 31.5. Pharmacosmos Therapeutics Inc.
• 31.6. AFT Pharmaceuticals Ltd.
• 31.7. Rockwell Medical Inc.
• 31.8. Akebia Therapeutics Inc.
• 31.9. Otsuka Pharmaceutical Co Ltd
• 31.10. AdvaCare Pharma USA LLC
• 31.11. Apotex Inc.
• 31.12. Ironic Biotech AB
• 31.13. KYE Pharmaceuticals Inc.
• 31.14. Emcure Pharmaceuticals Limited
• 31.15. Shield Therapeutics plc

32. Global Iron Deficiency Anemia Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Iron Deficiency Anemia Therapy Market

34. Recent Developments In The Iron Deficiency Anemia Therapy Market

35. Iron Deficiency Anemia Therapy Market High Potential Countries, Segments and Strategies

• 35.1 Iron Deficiency Anemia Therapy Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Iron Deficiency Anemia Therapy Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Iron Deficiency Anemia Therapy Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer